TGFB1 and hepatocellular carcinoma: In terms of HCC, as a submember of the TGF-β family, BMP4 was reported by Shen et al. to accelerate mesenchymal marker-induced oxaliplatin resistance via MEK/ERK/ELK1 signaling activation [43].